
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES189
This double-blind study over 12 months compared the combination of extended-release
fluvastatin 80 mg and fenofibrate 200 mg and the monotherapy of fenofibrate 20 mg, N=48 participants.295 At 6 months the combination showed a significantly higher reduction in LDL-C compared with fenofibrate monotherapy. For the 12-month point significantly there were greater reductions in LDL-C and TG levels and increases in HDL-C with the combination group compared with the monotherap. Adverse events
No serious AEs were reported, N=3 discontinued in the study due to myalgia. Level 1++

[@DEROSA_2004]

